LogicBio Therapeutics, Inc. (LOGC): Price and Financial Metrics
LogicBio Therapeutics, Inc. (LOGC)
Today's Latest Price: $10.00 USD
0.37 (-3.57%)
Updated Oct 22 6:55pm
Add LOGC to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 52 in Medical - Diagnostics/Research
See all "A" rated Strong Buy stocks
LOGC Daily Price Range
LOGC 52-Week Price Range
LOGC Stock Price Chart More Charts
LOGC Price/Volume Stats
| Current price | $10.00 |
| Prev. close | $10.37 |
| Day low | $10.00 |
| Day high | $10.40 |
| 50-day MA | $9.80 |
| 200-day MA | $11.06 |
| 52-week high | $20.07 |
| 52-week low | $6.34 |
| Volume | 35,500 |
| Avg. volume | 24,091 |
| Dividend yield | N/A |
| Market Cap | 224.94M |
LogicBio Therapeutics, Inc. (LOGC) Company Bio
LogicBio Therapeutics, Inc. is a genome editing company, which engages in developing medicines to treat rare diseases in patients with significant unmet medical need. It focuses on the commercialization of specific genome editing and integration of the therapeutic transgene. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Cambridge, MA.
Top Stories View All
Best & Worst Performing Stock Industries for October 22, 2019
Best & Worst Performing Small Cap Stocks for October 22, 2019
Best & Worst Performing Mid Cap Stocks for October 22, 2019
Best & Worst Performing Large Cap Stocks for October 22, 2019
Best & Worst Performing Mega Cap Stocks for October 22, 2019
View All Top Stories
Loading social stream, please wait...